Authors:
Gaston, R
Alloway, RR
Gaber, AO
Rossi, SJ
Schroeder, TJ
Irish, WD
Canafax, DM
First, MR
Citation: R. Gaston et al., Pharmacokinetic and safety evaluation of SangCya vs Neoral or Sandimmune in stable renal transplant recipients, TRANSPLAN P, 31(1-2), 1999, pp. 326-327
Authors:
Fisher, RA
Pan, SH
Rossi, SJ
Schroeder, TJ
Irish, WD
Canafax, DM
Lopez, RR
Citation: Ra. Fisher et al., Pharmacokinetic comparison of two cyclosporine A formulations, SangCya (Sang-35) and Neoral, in stable adult liver transplant recipients, TRANSPLAN P, 31(1-2), 1999, pp. 394-395
Authors:
Canafax, DM
Irish, WD
Moran, HB
Squiers, E
Levy, R
Pouletty, P
First, MR
Christians, U
Citation: Dm. Canafax et al., An individual bioequivalence approach to compare the intrasubject variability of two ciclosporin formulations, SangCya (TM), and Neoral (R), PHARMACOL, 59(2), 1999, pp. 78-88
Authors:
Tkatch, LS
Kusne, S
Irish, WD
Krystofiak, S
Wing, E
Citation: Ls. Tkatch et al., Epidemiology of Legionella pneumonia and factors associated with Legionella-related mortality at a tertiary care center, CLIN INF D, 27(6), 1998, pp. 1479-1486